Opportunity Information: Apply for RFA 386 15 000001

  • The India USAID New Delhi in the health sector is offering a public funding opportunity titled "Tuberculosis Health Action Learning Initiative (THALI)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001 USAID Foreign Assistance for Programs Overseas.
  • This funding opportunity was created on Apr 1, 2015 and posted on Apr 1, 2015.
  • Applicants must submit their applications by May 1, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $22,500,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $9,500,000.00 in funding.
  • The number of recipients for this funding is limited to 3 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
  • Local Indian Organizations
Apply for RFA 386 15 000001

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Tuberculosis Health Action Learning Initiative (THALI) is a USAID/India discretionary funding opportunity focused on improving tuberculosis (TB) control in India, with a specific emphasis on strengthening how TB services are delivered through the private sector. The core idea behind THALI is not only to improve outcomes where the program operates, but also to deliberately generate practical, field-tested learning about what approaches work best and then share those lessons more broadly so they can be applied elsewhere. The activity is designed to be implemented across three different city sizes, which signals an intent to test and adapt TB control strategies in varied urban contexts and compare what succeeds across different scale and health market conditions.

Funding is expected to be issued through cooperative agreements, which typically means the funder anticipates substantial involvement in program design refinement, oversight, and ongoing collaboration during implementation rather than a more hands-off grant. USAID/India indicated it may make up to three awards under this solicitation. The estimated total funding amount for the opportunity is USD 22,500,000, with individual awards anticipated to fall within an award floor of USD 5,500,000 and an award ceiling of USD 9,500,000. The opportunity also includes a cost sharing or matching requirement, meaning selected recipients would need to contribute a portion of project resources, whether in cash or allowable in-kind support, consistent with the announcement requirements.

At the time of the announcement, the application process was structured in stages. USAID/India initially accepted concept papers only, and planned to invite full applications only from those applicants whose concept papers received the strongest reviews. This approach is meant to reduce burden on applicants and the agency by narrowing the pool before requiring full technical and budget submissions. All communications for the opportunity, including questions and concept paper submissions, were directed to a single email address: IndiaRCO@usaid.gov, underscoring that applicants were expected to use that channel for official correspondence and submissions.

Eligibility was limited to local Indian organizations, as specified in the eligibility information, and the funding was categorized under health, with the CFDA listing 98.001 (USAID Foreign Assistance for Programs Overseas). The opportunity was posted on April 1, 2015, with an original and current closing date of May 1, 2015, and an archive date of May 31, 2015. The issuing office was USAID/India in New Delhi. For applicants who could not access the full announcement electronically, the notice provided a point of contact: Jeremy Arensdorf, Senior Assistance Specialist, with a listed phone number (202 626 8775), indicating an alternative support route for access and administrative assistance related to the solicitation.

Frequently Asked Questions (FAQs) - Tuberculosis Health Action Learning Initiative (THALI)

1) What is the Tuberculosis Health Action Learning Initiative (THALI)?

THALI is a USAID/India discretionary funding opportunity focused on improving tuberculosis (TB) control in India. A key emphasis is strengthening how TB services are delivered through the private sector.

2) What is the main goal of this funding opportunity?

The opportunity aims to improve TB outcomes in program areas and intentionally generate practical, field-tested learning about which approaches work best. Those lessons are meant to be shared more broadly so they can be applied in other settings.

3) Why does THALI emphasize learning and sharing lessons?

THALI is designed not only as an implementation activity, but also as a way to test approaches in real-world conditions, identify what works, and share evidence and practical insights for wider use beyond the immediate project locations.

4) What kinds of settings will THALI be implemented in?

The activity is designed to be implemented across three different city sizes. This indicates an intent to test and adapt TB control strategies in varied urban contexts and compare what succeeds across different scales and health market conditions.

5) Which sector is specifically emphasized for TB service delivery?

The opportunity places specific emphasis on strengthening TB services delivered through the private sector.

6) What type of funding instrument is expected for awards?

Funding is expected to be issued through cooperative agreements.

7) What does it mean that awards are expected to be cooperative agreements?

Cooperative agreements typically mean the funder anticipates substantial involvement during implementation, such as collaboration, oversight, and refinement of program design, rather than a more hands-off grant approach.

8) How many awards might USAID/India make under this solicitation?

USAID/India indicated it may make up to three awards under this solicitation.

9) What is the estimated total funding amount for the opportunity?

The estimated total funding amount is USD 22,500,000.

10) What is the expected funding range for individual awards?

Individual awards are anticipated to fall within an award floor of USD 5,500,000 and an award ceiling of USD 9,500,000.

11) Is cost sharing or matching required?

Yes. The opportunity includes a cost sharing or matching requirement. Selected recipients would need to contribute a portion of project resources, either in cash or allowable in-kind support, consistent with the announcement requirements.

12) What was the application process structure (stages) described in the announcement?

The process was structured in stages. USAID/India initially accepted concept papers only and planned to invite full applications only from those applicants whose concept papers received the strongest reviews.

13) Why did the opportunity use a concept paper first approach?

This approach was intended to reduce burden on applicants and the agency by narrowing the pool before requiring full technical and budget submissions.

14) How were applicants supposed to submit questions and concept papers?

All communications for the opportunity, including questions and concept paper submissions, were directed to a single email address: IndiaRCO@usaid.gov.

15) What email address was designated for official correspondence and submissions?

The designated email address was IndiaRCO@usaid.gov.

16) Who was eligible to apply?

Eligibility was limited to local Indian organizations, as specified in the eligibility information.

17) What sector/category was the funding listed under?

The funding was categorized under health.

18) What CFDA listing was associated with this opportunity?

The CFDA listing provided was 98.001 (USAID Foreign Assistance for Programs Overseas).

19) When was the opportunity posted?

The opportunity was posted on April 1, 2015.

20) What was the closing date for the opportunity?

The original and current closing date listed was May 1, 2015.

21) When was the opportunity scheduled to be archived?

The archive date listed was May 31, 2015.

22) Which office issued the solicitation?

The issuing office was USAID/India in New Delhi.

23) What support was available if an applicant could not access the full announcement electronically?

The notice provided a point of contact for access and administrative assistance: Jeremy Arensdorf, Senior Assistance Specialist, with a listed phone number of 202 626 8775.

24) Who was the listed point of contact for access or administrative help?

Jeremy Arensdorf, Senior Assistance Specialist, was listed as the point of contact for applicants who could not access the full announcement electronically.

25) What phone number was provided for the point of contact?

The phone number provided was 202 626 8775.

Browse more business programs for Tuberculosis Research

Browse more opportunities from the same agency: India USAID New Delhi

Browse more opportunities from the same category: Health

Next opportunity: Interns for Cultural Resources

Previous opportunity: Cooperative Ecosystem Studies Unit, Chesapeake Watershed CESU

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA 386 15 000001

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA 386 15 000001) also looked into and applied for these:

Funding Opportunity
NIBIB Research Education Programs for Residents and Clinical Fellows (R25) Apply for PAR 15 167

Funding Number: PAR 15 167
Agency: National Institutes of Health
Category: Health
Funding Amount: $70,000
PPHF 2015 Cooperative Agreements for State Sponsored Youth Suicide Prevention and Early Intervention (PPHF 2015) Apply for SM 15 004

Funding Number: SM 15 004
Agency: Substance Abuse Mental Health Services Adminis.
Category: Health
Funding Amount: $736,000
Alzheimers Drug Development Program (U01) Apply for PAR 15 174

Funding Number: PAR 15 174
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
PPHF 2015 Empowering Older Adults and Adults with Disabilities through Chronic Disease Self Management Education Programs Financed Solely by 2015 Prevention and Public Health Funds (PPHF 2015) Apply for HHS 2015 ACL AOA CS 0094

Funding Number: HHS 2015 ACL AOA CS 0094
Agency: Administration for Community Living
Category: Health
Funding Amount: $900,000
Epicenters for the Prevention of Healthcare Associated Infections (HAI) Cycle II Apply for RFA CK 15 004

Funding Number: RFA CK 15 004
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $2,200,000
Native Hawaiian Health Care Improvement Act Apply for HRSA 15 017

Funding Number: HRSA 15 017
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01) Apply for PAR 15 172

Funding Number: PAR 15 172
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Oral Immune System Plasticity in Chronic HIV Infection Under Treatment and Oral Co Infections (R01) Apply for RFA DE 16 002

Funding Number: RFA DE 16 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pre Application for Collaborative Innovation Award, CTSA Program (X02) Apply for PAR 15 173

Funding Number: PAR 15 173
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Methods Development in Natural Products Chemistry (R41/R42) Apply for RFA AT 16 004

Funding Number: RFA AT 16 004
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Methods Development in Natural Products Chemistry (R43/R44) Apply for RFA AT 16 003

Funding Number: RFA AT 16 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Phenotypic and Functional Studies on FOXO3 Human Longevity Variants to Inform Potential Therapeutic Target Identification Research (R01) Apply for PAR 15 175

Funding Number: PAR 15 175
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases and Tuberculosis Prevention (NCHHSTP) Public Health Conference Support Apply for CDC RFA PS15 1507

Funding Number: CDC RFA PS15 1507
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $125,000
Developing professional training programs to increase capacity for effective global health response to humanitarian emergencies Apply for CDC RFA GH15 1624

Funding Number: CDC RFA GH15 1624
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $100,000
Improving Response to and Programming in Humanitarian Emergencies Apply for CDC RFA GH15 1623

Funding Number: CDC RFA GH15 1623
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Understanding and Improving Diagnostic Safety in Ambulatory Care Incidence and Contributing Factors (R01) Apply for PA 15 180

Funding Number: PA 15 180
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $350,000
The NINDS Human Cell and Data Repository (U24) Apply for RFA NS 15 009

Funding Number: RFA NS 15 009
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
The NINDS Human Biomarkers Biospecimen and Data Repository (U24) Apply for RFA NS 15 010

Funding Number: RFA NS 15 010
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Understanding and Improving Diagnostic Safety in Ambulatory Care Strategies and Interventions (R18) Apply for PA 15 179

Funding Number: PA 15 179
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $350,000
Tuberculosis Call to Action (TBC2A) Apply for RFA 386 15 000003

Funding Number: RFA 386 15 000003
Agency: India USAID New Delhi
Category: Health
Funding Amount: $6,000,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA 386 15 000001", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.